Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats

Hypertension
Kohzo NagataMitsuhiro Yokota

Abstract

Chronic elevation of plasma aldosterone contributes to heart failure. Mineralocorticoid receptor (MR) antagonism is cardioprotective in such a setting, but whether such protection occurs in the presence of low-aldosterone concentrations remains unclear. We investigated whether MR blockade attenuates cardiac hypertrophy and failure in rats with salt-sensitive hypertension. Dahl salt-sensitive (DS) rats fed a high-salt diet from 7 weeks develop concentric left ventricular (LV) hypertrophy secondary to hypertension at 12 weeks followed by heart failure at 19 weeks (DS-CHF). DS rats on such a diet were treated with a non-antihypertensive dose of the selective MR antagonist eplerenone from 12 to 19 weeks. Renin activity and aldosterone concentration in plasma were decreased in DS-CHF rats compared with controls. LV hypertrophy and fibrosis, as well as macrophage infiltration around coronary vessels, were apparent in DS-CHF rats. The amounts of mRNAs for 11beta-hydroxysteroid dehydrogenase type 1, MR, monocyte chemoattractant protein 1, and osteopontin were increased in these hearts. Treatment of DS-CHF rats with eplerenone inhibited these changes in gene expression, as well as coronary vascular inflammation and heart failure. Eplere...Continue Reading

References

Apr 18, 1991·The New England Journal of Medicine·M H AldermanJ H Laragh
Aug 16, 2001·Trends in Endocrinology and Metabolism : TEM·R Rocha, C T Stier
Aug 3, 2002·Hypertension·Kohzo NagataMitsuhiro Yokota
Oct 5, 2002·Hypertension·Agostino VirdisErnesto L Schiffrin
Oct 18, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Ricardo RochaJohn A Delyani
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Apr 8, 2003·Journal of the American College of Cardiology·John M FlackElijah Saunders
May 29, 2003·American Journal of Physiology. Renal Physiology·Michelle L GumzBrian D Cain
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·Marcus Quinkler, Paul M Stewart
Jun 7, 2003·Circulation Research·Wenning QinEllen G McMahon
Sep 4, 2003·Circulation·Mónica RupérezMarta Ruiz-Ortega
Mar 11, 2004·Journal of Molecular and Cellular Cardiology·Mohammed Shakil AhmedHåvard Attramadal
Jun 17, 2004·Current Opinion in Nephrology and Hypertension·Felix J FreyBrigitte M Frey
Jul 28, 2004·Journal of Molecular and Cellular Cardiology·Timothy J KempAngela Clerk
Dec 16, 2004·Journal of Cardiac Failure·Marina P OkoshiBeverly H Lorell
Apr 30, 2005·The Journal of Steroid Biochemistry and Molecular Biology·John W Funder

❮ Previous
Next ❯

Citations

Nov 1, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Wenxia Chai, A H Jan Danser
Nov 20, 2008·Pflügers Archiv : European journal of physiology·Michael Gekle, Claudia Grossmann
May 3, 2013·Pflügers Archiv : European journal of physiology·Amy McCurleyIris Z Jaffe
Apr 17, 2010·Bulletin of Experimental Biology and Medicine·L A FedoseevaA L Markel
Apr 20, 2007·Current Hypertension Reports·John W Funder
Sep 4, 2008·Current Hypertension Reports·Kohzo Nagata
Jul 16, 2009·Current Hypertension Reports·Rajesh JanardhananScott D Solomon
Jun 5, 2010·Current Hypertension Reports·Cheryl L Laffer, Fernando Elijovich
Feb 9, 2012·Current Hypertension Reports·Anastasia S Mihailidou
Jun 13, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Miki Nagase, Toshiro Fujita
Jan 21, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinpei KimuraYoshifusa Aizawa
Sep 16, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tamayo MuraseKohzo Nagata
Jan 20, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Nicole L RosinJean-Francois Légaré
Apr 8, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yuichiro YamadaKohzo Nagata
Apr 8, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Taishi NakamuraShokei Kim-Mitsuyama
Mar 18, 2010·Nature Reviews. Nephrology·Marie Briet, Ernesto L Schiffrin
Apr 27, 2013·Cardiovascular Research·Begoña LópezJavier Díez
Apr 25, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Hyun Seok HwangMarvin O Boluyt
Jan 9, 2009·Journal of Cardiovascular Pharmacology·Philip E BrandishJames C Hershey
Jan 18, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Javad HabibiJames R Sowers
Dec 30, 2011·American Journal of Nephrology·Adam T Whaley-ConnellJames R Sowers
Oct 20, 2011·Cardiovascular Diabetology·Markus ReschDierk H Endemann
Mar 17, 2011·Medicine and Science in Sports and Exercise·Everton Crivoi Do CarmoEdilamar Menezes de Oliveira
Feb 6, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazuhiro YamamotoToshiaki Mano
Jun 26, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mitsuo TakedaHiroaki Matsubara
Aug 22, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Qingfen ZhangKazuwa Nakao
Mar 25, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Minori NakamotoShuichi Takishita
Mar 19, 2011·Journal of the American Society of Nephrology : JASN·Wiebke FenskeUNKNOWN German Diabetes, Dialysis Study Investigators
Sep 21, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takuya HattoriKohzo Nagata
Nov 21, 2013·Steroids·M GekleC Grossmann
Jun 3, 2009·Current Heart Failure Reports·Marcelle D SmitDirk J van Veldhuisen
Jun 14, 2008·Journal of Hypertension·Anton H van den Meiracker, Wendy W Batenburg
May 22, 2009·Journal of Hypertension·Yutaka KakizoeKimio Tomita
Feb 13, 2007·Current Opinion in Nephrology and Hypertension·Anette FiebelerFriedrich C Luft

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.